The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

The Obesity Care Advocacy Network (OCAN), and more than 70 other patient advocacy organizations across the spectrum of related obesity co-morbidities, issued a statement urging the Trump ...

The Food and Drug Administration on Tuesday proposed requiring new nutrition labels on the front of food and beverage products, a long-awaited move aimed at changing eating habits associated with ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

The Food and Drug Administration announced a new proposal Tuesday that would require food and drink manufacturers to place ...

Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...